As former president and CEO of Inovio Pharmaceuticals, Inc. (formerly Inovio Biomedical Corporation), Dr. Dhillon successfully created a vertically integrated DNA vaccine development company with one of the strongest development pipelines in the industry. Dr. Dhillon also raised over $125 million and secured more than $200 million in licensing deals from global companies including Merck and Wyeth (now Pfizer).Dr. Dhillon was a founding board member of Protox Therapeutics, Inc. and currently sits on the Board of Directors of BC Advantage Funds, the largest Venture Capital Corporation in British Columbia.Dr. Dhillon is also the Co-Founder and Chairman at Vitality Biopharma.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
![]() |
Director | — | — | Detail |